Sleeping Pills induces sleep, which could be an effective treatment for chronic insomnia. Sleeping drugs or pills are powerful hypnotic; hence, can cause a strong urge to sleep. Chronic insomnia could have a negative impact on an individual’s health such as increased risk of depression, high blood pressure, and could also lower the quality of life or lifestyle. Sleep deprivation could cause neural problems that could lower the productivity of work done by an individual and can cause hypertension, stress, and depression. Some of the common sleeping pills taken worldwide are Zaleplon, Eszopiclone, Benzodiazepines, Temazepam, and others.
The study of NCBI stated that chronic insomnia was seen in 33% of the adult population that was being sampled. Rising age and diabetes were found to be significantly associated with insomnia disorder, 27% of patients who had insomnia did not perceive the condition, which was statistically significant.
Download PDF Sample with Popular Trends @ https://goo.gl/bW5EJE
The factors that have a positive impact on the growth of the global sleeping drug market include growing per capita healthcare expenditure in developing economies, growing prevalence of insomnia, growing awareness programs regarding the importance of ample sleep, and rising demand for sleeping pills in modern and fast lifestyle.
However, due to the side-effects of sleeping drugs in today’s market, alternatives and conventional sleeping aids are more favorable, these include acupuncture, herbal or dietary medicine, homeopathy, and bodywork or yoga, and others. Sleeping pills are generally taken for a short period of time, ideally less than two weeks and are advised to be consumed intermittently. This may hamper the market growth in future.
Geographically, the global sleeping pills market is divided into North America, Europe, Asia Pacific, and Latin America, Middle East and Africa. North America is attributed to have the significant share in the market with countries like U.S and Canada, owing to rising count of insomniac individuals. It is attributed that 50 to 70 million Americans chronically suffer from a disorder of sleep, impeding daily functioning and badly affecting their health (PubMed). As per the report of American Academy of Sleep Medicine, nearly 30 to 35% of the U.S population has the symptoms of brief insomnia. Around 15 to 20% people of the total U.S population have a short-term insomnia disorder, and 10% are accounted to have a chronic insomnia disorder, which usually occurs at least three times weekly for at least three months. This increasing sleep disorders and the rising insomniac population can contribute to North America’s market growth.
Check Discount of This Report @ https://goo.gl/JuDA6P
Europe market is expected to share the same potential with the countries like Germany, France, U.K, Spain, Italy, and others. According to the study of a Men’sHealth magazine (U.K), over 12 million prescriptions for insomnia disorder was handed out to help people to get a full eight hours sleep.
An upsurge in the prevalence of sleep disorders owing to changing lifestyle, rising number of patients suffering from sleep disorders in the Asia Pacific such as India, Japan, China, Russia, Pakistan, and others are attributed to boost the global embolic protection devices market. LAMEA market is also attributed to grow in the upcoming years with the emerging countries such as Brazil, Argentina, South Africa, and Others.
The global key manufacturers of an anembolic protection devices market are:
• Merck & Co., Inc. (U.S)
• GlaxoSmithKline plc. (U.K)
• CareFusion (U.S)
• Apotex Inc. (Canada)
• Sanofi (France)
• Takeda Pharmaceutical Company Limited. (Japan)
• Pfizer Inc. (U.S)
• Eli Lilly and Company (U.S)
• Dr. Reddy’s Laboratories Ltd (India)
The global sleeping pills market is bifurcated on the following bases:
• Non Benzodiazepines
• Short-term Use
• Long-term Use
Long-term use of sleeping pills is expected to fuel the market growth.
Reports Monitor is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries including Healthcare, Technology, Chemicals, Materials, and Energy. With an intrinsic understanding of many business environments, Reports Monitor provides strategic objective insights.
We periodically update our market research studies to ensure our clients get the most recent, relevant, and valuable information. Reports Monitor has a strong base of analysts and consultants from assorted areas of expertise. Our industry experience and ability to zero-in on the crux of any challenge gives you and your organization the ability to secure a competitive advantage.